BioLife Solutions Inc. (NASDAQ: BLFS) has scheduled the release of its fourth quarter and full-year 2025 financial results for February 26, 2026. The company will present its earnings report followed by a live conference call and webcast beginning at 4:30 p.m. Eastern Time, during which senior management will review the company's financial performance and operational achievements throughout the year.
Investors and analysts will have the opportunity to hear directly from BioLife Solutions leadership regarding the company's results and strategic direction. The live webcast will be available to the public, with details on accessing the call expected to be provided in advance of the scheduled announcement.
BioLife Solutions, which specializes in preservation and storage solutions for cellular and gene therapies, continues to serve a critical role in the biopharmaceutical supply chain. The company's earnings call will offer insight into its performance amid growing demand in the cell and gene therapy sectors.
